GH Power, the Pioneering Clean Energy and Critical Materials Company, to Go Public through Business Combination with Matinas BioPharma
GH Power Inc. said it agreed to combine with Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) in a deal expected to create a NYSE-listed clean energy and critical minerals company. GH Power’s modular reactor tech would be scaled for hydrogen, heat, power, and alumina. A PIPE of at least $15.0M is planned, and the deal is expected to close in Q4 2026.
How this was made
The 30-second read
Why it matters
The article provides concrete deal mechanics (ownership split, share conversion ratio, and closing conditions) and a minimum PIPE size of $15.0 million, which together define the primary trading catalysts and risks for the involved public equity.
Market read
This is a deal-driven catalyst with defined milestones (PIPE, SEC Form F-4, shareholder and court approvals) and a stated post-close ownership split, making it relevant for event-driven positioning.
What to watch
Key gating items include PIPE size completion, SEC registration statement timing, and court approvals; delays or financing shortfalls could materially change deal economics.
Background
GH Power announced a definitive business combination agreement with Matinas to form a NYSE-listed critical minerals and clean energy company centered on GH Power’s modular reactor technology and related hydrogen, heat, power, and advanced materials platform.
Ticker impact
Matinas entered a definitive business combination agreement with GH Power, with its shares converted into GHP International shares at closing.
Likely volatility around deal headlines and upcoming shareholder/SEC milestones; direction depends on implied valuation and financing terms.
The article discloses the transaction structure, ownership split (about 9% for Matinas holders post-close), and key closing conditions, but provides no valuation or pro-forma financials.
Market effects
Highlights continued capital-market interest in modular nuclear-adjacent power, green hydrogen, and critical materials supply chains.
Emphasizes project development and commercialization across North America and Europe, potentially affecting regional clean-energy development expectations.
Positions the combined company to participate in long-term investment themes around industrial decarbonization and onshoring critical mineral production.
Counterpoint
The deal may be more about accessing public capital than near-term commercialization, so valuation and dilution risk could dominate returns.
Key entities
- companyGH Power Inc.
Technology developer of proprietary modular reactor systems converting scrap metals and water into high-purity alumina, clean hydrogen, and thermal energy.
- companyMatinas BioPharma Holdings, Inc.
NYSE American-listed company entering the business combination; its LNC technology platform and MAT2203 are referenced as being sold to Azurity.
- companyGHP International
Newly formed public parent expected to be named GH Power International, holding GH Power and Matinas subsidiaries post-close.
- companyAzurity
Referenced as the buyer of the LNC technology platform and MAT2203.
